Compass Therapeutics, Inc. Profile Avatar - Palmy Investing

Compass Therapeutics, Inc.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-…

Biotechnology
US, Boston [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Compass Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Compass Therapeutics, Inc. has no acquisition track records yet.

End of CMPX's Analysis
CIK: 1738021 CUSIP: 20454B104 ISIN: US20454B1044 LEI: - UEI: -
Secondary Listings
CMPX has no secondary listings inside our databases.